Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network

NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the expansion of its provider network to include reproductive urologists (RU). Patients with Progyny’s comprehensive and equitable solution will now have convenient access to high-quality urological care, in addition to the existing Progyny network made up of more than 650 clinics and over 950 leading fertility specialists.

Currently, about one third of infertility cases are due to one partner being unable to create and ejaculate healthy sperm, often referred to as male-factor infertility. While Progyny has already been covering several treatments for sperm-related infertility through its reproductive endocrinology and infertility (REI) network, there are those who need further evaluation from a RU, a doctor who specializes in reproductive health for people who produce sperm. Progyny is proud to now offer coverage and access to a curated network of accredited RUs for those individuals.

“Infertility impacts millions of people and sperm related infertility accounts for a sizable portion, yet most of the conversation and responsibility falls to the female population,” said Pete Anevski, Progyny’s CEO. “At Progyny, we work to address all areas of infertility to provide the best services and treatments possible to ensure everyone’s dreams of parenthood are realized. Expanding our male fertility offering to include a RU network of best-in-class physicians is a vital step to furthering this mission.”

To expand Progyny’s provider network, the company worked closely with its well-respected REI partners to distinguish RUs that provide best-in-class urological care. Each RU has been vetted to meet Progyny’s network standards and will work collaboratively with the REIs to ensure a streamlined and cohesive patient experience.

“I am very excited to be involved in the roll-out of Progyny’s extended coverage for male-factor infertility. This is a great opportunity for patients to have expanded coverage to optimize their chances of achieving their family building goals,” said Dr. Shane Russell, a reproductive urologist in Progyny’s network. “The Progyny team has been great to work with and I look forward to a long and productive partnership with them.”

To find a reproductive urologist in Progyny’s network, please visit: https://providersearch.progyny.com/.

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians. 

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago